Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: CoffeePot who wrote (1068)	11/6/1998 12:55:00 AM
From: Mike McFarland	Respond to of 3576

(snip) ...Gearhart said. He explained that ''more specific cells could become transplant therapies for diabetes, spinal cord injury, neurodegenerative disorders like Parkinson's disease, muscular dystrophies, atherosclerosis and wound healing.''(snip) Holy grail indeed...though some might say sacrilege, hehe. I would imagine they'll be growing simple things for a decade, growing nerves and organs sounds like science fiction. Of course in a lifetime science fiction can become reality. I'm sure a lot of folks will make money on the volatility tommorrow. I myself have followed Mr. Harmon into a few stocks, and Biotransplant comes to mind in this situation. (I'm not ashamed to get a little plug in there while I'm here). My hope would be that if science can start to grow interesting things from stem cells, than solving rejection problems for porcine organs is child's play a decade from now...and BTRN or some company like it wins the race. Just some thoughts, hope nobody on the thread takes offense at my intrusion--I am sure owners of GERN will do great Friday...heck, if I'd been monitoring the daytrader threads yesterday I'd have bought some too. happy trading, MM